Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

meningococcal group B vaccine

meningococcal group B vaccine
  • Restricted Vaccines Formulary
  • Restricted Trumenba --> Restricted to latex allergy, post-splenectomy patients or outpatients.
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Bexsero SUSPENSION, INTRAMUSCULAR 0.5 mL      
Trumenba SUSPENSION, INTRAMUSCULAR 0.5 mL    


Comments:

Bexsero: Restricted to post-splenectomy patients or outpatients. (Contains Latex)

Trumenba: Restricted to latex-allergic, post-splenectomy patients or outpatients.

Automatic interchange of inpatient orders for Trumenba to Bexsero.

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

meningococcal group B vaccine (Trumenba)

  • 0.5 mL IM injection

meningococcal group B vaccine (Bexsero)

  • 0.5 mL IM injection

Once a vaccination series is initiated, complete the series with the same product (Bexsero: 2-dose series, Trumenba: 3-dose series).


Reviewed: 22 March 2016


Last updated: Dec. 26, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.